These results demonstrated that AML can be generated in immuno-competent mice by a synonymous mutant of MLL-AF4 and suggested that post-transcriptional regulation plays a critical role in controlling the oncogenic activity of MLL-AF4. This evidence concerns the gene AFF1 and acute myeloid leukemia.